Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress.
Studies on the amyloid precursor protein (APP) have suggested that it may be neuroprotective against amyloid-beta (Abeta) toxicity and oxidative stress. However, these findings have been obtained from either transfection of cell lines and mice that overexpress human APP isoforms or pretreatment of APP-expressing primary neurons with exogenous soluble APP. The neuroprotective role of endogenously expressed APP in neurons exposed to Abeta or oxidative stress has not been determined. This was investigated using primary cortical and cerebellar neuronal cultures established from APP knock-out (APP-/-) and wild-type (APP+/+) mice. Differences in susceptibility to Abeta toxicity or oxidative stress were not found between APP-/- and APP+/+ neurons. This observation may reflect the expression of the amyloid precursor-like proteins 1 and 2 (APLP1 and APLP2) molecules and supports the theory that APP and the APLPs may have similar functional activities. Increased expression of cell-associated APLP2, but not APLP1, was detected in Abeta-treated APP-/- and APP+/+ cultures but not in H2O2-treated cultures. This suggests that the Abeta toxicity pathway differs from other general forms of oxidative stress. These findings show that Abeta toxicity does not require an interaction of the Abeta peptide with the parental molecule (APP) and is therefore distinct from prion protein neurotoxicity that is dependent on the expression of the parental cellular prion protein.
Department of Pathology, The University of Melbourne and The Mental Health Research Institute, Parkville, Victoria, Australia, 3052.
A R
AR
White
H
H
Zheng
D
D
Galatis
F
F
Maher
L
L
Hesse
G
G
Multhaup
K
K
Beyreuther
C L
CL
Masters
R
R
Cappai
D000544:Alzheimer Disease / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000494:pharmacology / Q000506:poisoning*; D016564:Amyloid beta-Protein Precursor / Q000031:analogs & derivatives / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology / Q000187:drug effects; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D018698:Glutamic Acid / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout / Q000235:genetics*; D009474:Neurons / Q000187:drug effects* / Q000502:physiology*; D018384:Oxidative Stress / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology; D013481:Superoxides / Q000494:pharmacology
C489697:APLP1 protein, human; D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; C078201:Aplp1 protein, mouse; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); C074636:amyloid beta-protein (25-35); D016222:Fibroblast Growth Factor 2; D013481:Superoxides; D018698:Glutamic Acid; D006861:Hydrogen Peroxide